Verified July 2026 · Cited to primary sources

Melanotan-1 (Afamelanotide / Scenesse): Evidence Grade A. FDA-approved / proven in humans.

Grade AFDA-approvedSafety: green

The honest verdict

Legitimate, best-in-class evidence for one narrow job: photoprotection in erythropoietic protoporphyria, where it is FDA-approved. For that use, Grade A. For the tanning use most people are actually asking about, you are buying an unapproved gray-market peptide with real melanoma-surveillance concerns and none of the approval-grade safety backing. Do not conflate the two.

Melanotan-1 (Afamelanotide / Scenesse) at a glance

Class
Melanocortin receptor agonist (alpha-MSH analog)
Mechanism
Afamelanotide is a synthetic, more stable analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It is a selective agonist at the melanocortin-1 receptor (MC1R) on melanocytes, driving synthesis of eumelanin in the skin independent of UV exposure. The extra eumelanin is photoprotective, which is the basis of its approved use.
Also known as
afamelanotide, Scenesse, melanotan I, MT-1, CUV1647, Nle4-D-Phe7-alpha-MSH, NDP-MSH
Research applications
  • Photoprotection in erythropoietic protoporphyria (EPP)
  • Investigated in X-linked protoporphyria, vitiligo, and other photodermatoses
  • Gray-market use as a tanning/skin-darkening agent (unapproved, not the same product)
Forms
16 mg controlled-release subcutaneous implant (Scenesse, prescription), Injectable lyophilized powder (research/gray-market melanotan-1, unregulated)
Legal status
FDA-approved
WADA (anti-doping)
Not specifically listed as a prohibited substance by WADA; not a recognized performance enhancer.
Evidence grade
Grade AFDA-approved / proven in humans

How we grade evidence

Every grade comes from a fixed A to F rubric: human-trial strength, not hype or affiliate status. Last verified July 6, 2026.

What is Melanotan-1 (Afamelanotide / Scenesse)?

The one melanotan that is actually an FDA-approved drug. As Scenesse, afamelanotide is a prescription implant for a rare light-sensitivity disorder, not the gray-market tanning peptide people buy online.

Afamelanotide is a synthetic, more stable analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It is a selective agonist at the melanocortin-1 receptor (MC1R) on melanocytes, driving synthesis of eumelanin in the skin independent of UV exposure. The extra eumelanin is photoprotective, which is the basis of its approved use.

How strong is the evidence for Melanotan-1 (Afamelanotide / Scenesse)?

Afamelanotide is FDA-approved (October 2019, Scenesse, NDA 210797) to increase pain-free light exposure in adults with erythropoietic protoporphyria, backed by two multicenter randomized, double-blind, placebo-controlled trials published in the New England Journal of Medicine (2015). That is Grade A evidence for its approved indication. Note: the evidence and approval cover the medical EPP use only. The tanning use that most people associate with melanotan-1 is NOT approved, NOT studied for safety in that context, and is a separate gray-market practice.

Primary sources (3)

  1. Langendonk et al., Afamelanotide for Erythropoietic Protoporphyria, NEJM 2015 (pivotal RCTs, PMID 26132941)
  2. FDA prescribing label: SCENESSE (afamelanotide) implant (DailyMed)
  3. NCBI LiverTox: Afamelanotide (confirms 2019 FDA approval, MC1R agonist)

What is Melanotan-1 (Afamelanotide / Scenesse) used for?

Melanotan-1 (Afamelanotide / Scenesse) is marketed for the goals below. See how it ranks against other peptides in each, by evidence, not hype.

What does Melanotan-1 (Afamelanotide / Scenesse) cost, and how do you access it legally?

Typical cost

Scenesse: roughly $30,000 to $60,000 per implant course (specialty, insurance-billed). Gray-market melanotan-1 vials: $20 to $60 each.

The two prices reflect two different products. Scenesse is a specialty orphan drug administered by a physician and billed through insurance for EPP; almost no one pays cash. The cheap vials are unregulated research-labeled peptide with no assurance of identity, purity, or dose.

How to access it legally

Melanotan-1 (Afamelanotide / Scenesse)is FDA-approved, so the legal route is a prescription from a licensed provider, not a research vial. We don't currently have a vetted partner to link for it, so there's no button here. Ask a licensed clinician about the branded product. We never point you to gray-market or compounded off-label sources.

Is Melanotan-1 (Afamelanotide / Scenesse)safe? Side effects & risks

Well-characterized human safety (FDA-approved or long clinical history)

As the approved drug Scenesse, the risk profile is well characterized: implant-site reactions, nausea, fatigue, headache, and skin hyperpigmentation are the common effects, and it darkens existing moles and freckles so twice-yearly full-body skin exams are advised. Serious hypersensitivity including anaphylaxis has been reported. The bigger safety story is the gray-market version: unregulated melanotan-1 sold for tanning is not the same quality-controlled product, is linked in case reports to new or changing melanocytic lesions and melanoma concerns, and self-injected sterility is a real risk. If you are considering it for tanning, understand you are stepping entirely outside the approved indication and its safety data.

Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.

FAQ

Melanotan-1 (Afamelanotide / Scenesse) FAQ

Is melanotan-1 FDA-approved?

The molecule is, under the name afamelanotide (brand Scenesse), approved in 2019 for erythropoietic protoporphyria. The tanning use sold online is not approved and is a separate, unregulated practice.

Is the melanotan-1 sold online the same as Scenesse?

No. Scenesse is a quality-controlled 16 mg physician-placed implant. Online melanotan-1 is research-labeled injectable powder with no guarantee of identity, purity, or dose, and no approved safety data for cosmetic tanning.

Does it actually tan skin?

Yes, it increases eumelanin and darkens skin. That pharmacology is real. The concern is that it also darkens moles and freckles, which complicates melanoma detection, so dermatologists advise regular skin checks.

From our portfolio

Tracking Melanotan-1 (Afamelanotide / Scenesse)?

Titrate is an iOS app for logging doses, schedules and progress over time, with a reconstitution calculator built in. It tracks, it does not prescribe.

Get Titrate for iOS →

Keep reading

The monthly peptide evidence brief.

What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.